N-ethylpyridinium bromide

We are N-ethylpyridinium bromide CAS:1906-79-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


English Name: N-ethylpyridinium bromide
Synonyms:1-ethyl-pyridiniubromide
Pyridinium, 1-ethyl-, bromide
1-Ethylpyridin-1-ium bromide
Pyridinium,1-ethyl-,bromide
Molecular Formula: C7H10BrN
Molecular Weight: 188.07
CAS No.: 1906-79-2
Purity: 99%
 
Technical Information

Appearance: Purity:
NMR: Passed null
Solubility: Insolubility:
Impurity content:
(1) Water content: < 1000 ppm

 
Physics-Chemistry Properties

Melting point: 118.16℃ Decomposition temperature: 207℃
Conductivity: Electrochemical window:
Viscosity: Density:

 
Our company has been engaged in the R&D, production of ionic liquids and related technologies for more than ten years. Since 2007, our company has supplied ionic liquid reagents to customers, and can provide customers with ionic liquid products from grams to hundreds of tons. The main product series are: Imidazolium ionic liquids, single-substituted Im ionic liquids, Disubstituted Im ionic liquids, Tri-Substituted Im ionic liquids, Pyrilidinium ionic liquids, Ammonium ionic liquids, Phosphonium ionic liquids, Pyrrolidinium ionic liquids, Piperidinium ionic liquids, Functionized ionic liquids, Vinyl-Based ionic liquids, Hydroxyl-Based ionic liquids, Ether-Based ionic liquids, Ester-Based ionic liquids, Carboxyl-Based ionic liquids, Nitrile-Based ionic liquids, Amido-Based ionic liquids, SulfoAcid-Based ionic liquids, Benzyl-Based ionic liquids, Guanidine-Based ionic liquids, Oxonium salts
 N-ethylpyridinium bromide


Related News: Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.125971-94-0 The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.18406-41-2 The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.3-chloropropyl(trimethoxy)silane The US National Institutes of Health is working on a preventative vaccine, but it will likely take a few months until the first phase of clinical trials get underway, and more than a year until a vaccine might be available, according to experts.The US National Institutes of Health is working on a preventative vaccine, but it will likely take a few months until the first phase of clinical trials get underway, and more than a year until a vaccine might be available, according to experts.

Related Products
Product Name
4,4-Diethoxy-N,N-dimethyl-1-butanamine View Details
3-Methyl-1-(4-sulfophenyl)-2-pyrazolin-5-one View Details
Trimethyl(perfluoroethyl)silane Cas:124898-13-1 View Details
trans-1,4-Dibromo-2-butene manufacturer O-Desmorpholinopropyl Gefitinib manufacturer 2-(5-Amino-1,2,4-Thiadiazol-3-yl)-2-(Methoxyimino)Acetic Acid manufacturer Methyl 2-methyl-3-nitrobenzoate manufacturer ((Difluoromethyl)sulfonyl)benzene Cas:1535-65-5 manufacturer